For the Inventor, By the Inventor

Enter assignee name

I.d.m. Immuno-Designed Molecules

Calculating rank

USPTO Granted Patents = 17

% Expired Patents = 11.8

Forward Citations = 140

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Jacques Bartholeyns (9 out of 12 patents)

Mohamed Chokri (9 out of 10 patents)

Jean-Loup Romet-Lemonne (6 out of 6 patents)

4. Michel Monsigny (4 out of 11 patents)

5. Patrick Midoux (3 out of 3 patents)

6. Yves Fouron (2 out of 6 patents)

7. Annie-Claude Roche-Degremont (2 out of 2 patents)

8. Patrick Erbacher (2 out of 2 patents)

9. Claire Boccaccio (1 out of 1 patent)

10. Jean-Pierre Abastado (1 out of 4 patents)

11. Alessandra Nardin (1 out of 2 patents)

12. Roger Mayer (1 out of 2 patents)

13. Nadia Sdiqui (1 out of 1 patent)

14. Annie-Claude Roche (1 out of 2 patents)

17 patents: Sort by Forward Citations

1. 7252996 - Ancillary composition for the preparation of committed mature dentritic cells (2007-08-07),

2. 6881413 - Humanized biomaterials, a process for their preparation and their applications (2005-04-19),

3. 6821516 - Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions (2004-11-23),

4. 6713056 - Combined preparation for the treatment of neoplasic diseases or of infectious diseases (2004-03-30),

5. 6616925 - Combined preparation for the treatment of neoplasic diseases or of infectious diseases (2003-09-09),

6. 6596275 - Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions (2003-07-22),

7. 6540994 - Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions (2003-04-01),

8. 6372499 - Polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes (2002-04-16),

9. 6251858 - Derivatives of oligosides, their process of preparation and their applications (2001-06-26),

10. 6221576 - Process for preparing macrophages, kits, and compositions for the use of this process (2001-04-24),

11. 6140122 - Process for preparing macrophages, kits, and compositions for the use of (2000-10-31),

12. 6051432 - Macrophages, process for preparing the same and their use as active (2000-04-18),

13. 6001351 - Macrophages, process for preparing the same and their use as active (1999-12-14),

14. 5804442 - Process for preparing macrophages, kits, and composition for the use of (1998-09-08),

15. 5733762 - Complexes of nucleic acid and polymer, their process of preparation and (1998-03-31),

Company Overview

I.d.m. Immuno-Designed Molecules, based in Paris, specializes in the development of innovative immunotherapies aimed at treating various diseases, including cancer. The company focuses on harnessing the power of the immune system through cutting-edge research in molecular design and biopharmaceuticals. By leveraging advanced technologies, I.d.m. aims to create targeted therapies that enhance patient outcomes and contribute to the evolving landscape of personalized medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

17 Patents

#273 in Paris

#1,167 in France

#36,017 in the World

I.d.m. Immuno-Designed Molecules

Forward Citations = 140

14 inventors:

Jacques Bartholeyns (9 out of 12 patents)

Mohamed Chokri (9 out of 10 patents)

Jean-Loup Romet-Lemonne (6 out of 6 patents)

4. Michel Monsigny (4 out of 11 patents)

5. Patrick Midoux (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: I.d.m. Immuno-Designed Molecules. Retrieved from https://idiyas.com/company/i-d-m-immuno-designed-molecules

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…